0001209191-18-009446.txt : 20180213
0001209191-18-009446.hdr.sgml : 20180213
20180213113609
ACCESSION NUMBER: 0001209191-18-009446
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160901
FILED AS OF DATE: 20180213
DATE AS OF CHANGE: 20180213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Williams Lewis T
CENTRAL INDEX KEY: 0001475714
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36070
FILM NUMBER: 18600948
MAIL ADDRESS:
STREET 1: C/O FIVE PRIME THERAPEUTICS, INC.
STREET 2: TWO CORPORATE DRIVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FIVE PRIME THERAPEUTICS INC
CENTRAL INDEX KEY: 0001175505
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 260038620
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 111 OYSTER POINT BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-365-5600
MAIL ADDRESS:
STREET 1: 111 OYSTER POINT BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2016-09-01
2016-09-01
0
0001175505
FIVE PRIME THERAPEUTICS INC
FPRX
0001475714
Williams Lewis T
111 OYSTER POINT BOULEVARD
SOUTH SAN FRANCISCO
CA
94080
1
1
0
0
Executive Chairman
Common Stock
2016-09-01
4
F
0
32613
44.74
D
431715
D
Common Stock
2016-09-01
4
G
0
22416
0.00
D
409299
D
This amendment is being filed to reflect the correct disposition of shares of common stock by the reporting person in satisfaction of a tax liability on September 1, 2016. The original Form 4 filed with the Securities and Exchange Commission on September 1, 2016 inadvertently included a disposal of 7,613 shares of common stock rather than 32,613 shares of common stock, as shown in this amendment.
This amendment reflects that the reporting person's gift of 22,416 shares of common stock reported in the original Form 4 filed with the Securities and Exchange Commission on September 1, 2016 was not a market transaction and as such, no price is reported in this amendment. The reporting person did not receive any value for the gifted shares.
/s/ Francis Sarena, Attorney-in-Fact
2018-02-13